The association between polypharmacy and late life deficits in cognitive, physical and emotional capability: a cohort study

Mina Khezrian (Corresponding Author), Christopher J. McNeil, Phyo K. Myint, Alison D. Murray

Research output: Contribution to journalArticle

4 Citations (Scopus)
6 Downloads (Pure)

Abstract

Background Polypharmacy is a growing health concern for older adults and is associated with poorer clinical outcome. Objective This study aim is to investigate the association between polypharmacy and impairment in cognitive, physical and emotional capability controlling for the confounding effect of co-morbidities. Setting The Aberdeen 1936 Birth Cohort from 1999 to 2004. Method Recruited were 498 dementia free participants around 64 years old and recruited into wave one. Linear regression and structural equation models were used. Models were adjusted for the effect of age, gender, childhood IQ, education and Body Mass Index. A triad of impairment was defined as a composite measure of impairment in cognitive, physical and emotional function. Main outcome measure The relationships between polypharmacy, co-morbidity and triad of impairment. Results The prevalence of polypharmacy was 12.3% in this relatively healthy sample. Polypharmacy was significantly associated with increased impairment in cognitive, physical and emotional ability (β = 3.6, p = 0.003) after controlling for the effect of comorbidities and other confounding variables. As expected, higher childhood IQ and educational achievement had protective effects against impairment while higher comorbidity score and Body Mass Index were associated with increased impairment in this population. Conclusions The independent association of polypharmacy and reduced cognitive, physical and emotional capability makes this a promising target for predicting and potentially reducing the risk of impairment and associated healthcare costs in older adults. Longitudinal studies are required to investigate the underlying mechanisms for the observed relationships further.
Original languageEnglish
Pages (from-to)251-257
Number of pages7
JournalInternational Journal of Clinical Pharmacy
Volume41
Issue number1
Early online date29 Nov 2018
DOIs
Publication statusPublished - Feb 2019

Keywords

  • Cognitive impairment
  • Emotional impairment
  • Observational cohort study
  • Older adults
  • Physical impairment
  • Polypharmacy
  • United Kingdom
  • RISK
  • FRAILTY
  • PREVALENCE
  • IMPACT
  • FRAMEWORK
  • HEALTH

Fingerprint Dive into the research topics of 'The association between polypharmacy and late life deficits in cognitive, physical and emotional capability: a cohort study'. Together they form a unique fingerprint.

Cite this